On August 25, the pharmaceutical network provided an opportunity to expand the market for retail drugs.A few days ago, in 2017 China's medicine retail industry (heap) conference, issued a "drug six terminal market in 2016 blue book" (hereinafter referred to as the "blue book"), the data show that in the policy, pushed by the outflow of prescription drugs into the trend, drug retail industry recovery, over the next 10 years the size of the market is expected to reach 172 million yuan, many traditional pharmaceutical companies, pharmacies are grasp layout prescription drug market.
With the scale, chain and specialization of retail pharmacies, it will be more convenient for the public to buy medicine, and the medicine will be safer.
Prescription drug outflows are good for the retail market
In the medical terminal market, the proportion of retail pharmacies is not high, according to the blue book.According to the data, the market of urban grade hospitals accounted for 55 percent of the pharmaceutical market in 2016, with 17.7 percent of county level hospitals, 6 percent of primary medical market and 16.4 percent of retail pharmacies.
"In places like Japan and the U.S. and Europe, 90 percent of pharmaceutical sales are in retail pharmacies.The domestic market for prescription drugs now accounts for just 20 per cent of the market, and there is a lot of room for improvement.According to wu han, President of the blue book publisher, China health information.
"With the advance of the policy, prescription drug outflows, retail at the social pharmacy, is an inevitable direction.""Mr Wu said.We have learned, at present, health and family planning commission is actively pushing DRGs (pay by disease diagnosis related group) model, in this mode, insurance fee to further strengthen, the risk of many varieties of prescription drugs exist out of the hospital channels.The market share of the retail drug market will gradually increase with the guidance of drug separation and prescription drug outflow.
In 2016, the market size of retail pharmacies was 337.7 billion yuan, an increase of 8.5 percent from 2015, which was higher than the overall growth of the drug market.According to the health information in the forecast, the next decade, in the pharmaceutical separation under the premise of fully implemented, retail drug market scale will reach 1.72 trillion yuan, accounting for about 65% of all drugs terminal market, "the equivalent of two medicines retail market."Wu han pointed out.
Drug companies speed up the layout
The DTP model is very popular
The market outlook for prescription drug outflows has also spurred a number of drug companies to aggressively seek out the drug market, starting with the distribution of prescription drugs.At the western conference, journalists have seen a number of traditional industrial pharmaceutical companies, such as yangzijiang pharmaceutical industry, zhengda tianqing, etc., to expand the retail market.
Indeed, the pharmaceutical industry's retail market is already a trend.Some foreign drug companies that have traditionally ignored the retail market have formed retail teams, including astrazeneca, Merck and sanofi.At the same time, retail pharmacies, the most direct beneficiaries of prescription drug outflows, are also beefing up their prescriptions.
Among them, DTP became the most popular model for drug companies and pharmacies.DTP pharmacy refers to drug manufacturers who bypass agents and license their products directly to pharmacies, where consumers can purchase them at the pharmacy.For example, the company has taken the lead in DTP pharmacy in recent years, and its annual report shows that the company has more than 30 DTP pharmacies, with revenues of more than 2 billion yuan.It is understood that almost all the enterprises that make tumor medicine now adopt DTP mode, and the number of them is up to 100.DTP has also been carried out in many pharmacy chains, such as jianke, yifeng pharmacy, single-minded hall and common people.
It's worth noting that in the category of prescription drug retail subcategories, anti-tumor and immuno-modulators have become increasingly important categories.In 2016, its market share in the retail prescription drug market increased by 60%, accounting for 4.05%, and its market share is expected to grow to 4.86% in 2017, according to China health data.Maintain a 40% growth rate.And early placement of DTP to take on prescription drugs is expected to benefit.
The outlook for online pharmacies remains unclear
The outflow of prescription drugs and retail pharmacies to layout, there are a number of chain pharmacy develop medical electrical contractor, or self-built platform, or cooperate with JPM medicine and so on 020 platform, "express" business to medicine.
According to the blue book, online pharmacies account for just 0.3 percent of the drug's six terminal markets.However, with the development of Internet disruption, the online pharmacies that originated in 2011 are still in the high growth stage and the market share is increasing.In 2016, the total sales volume of Chinese online pharmacies reached 16.6 billion yuan, up 50.9 percent from 2015, including 4.5 billion yuan of pharmaceutical products, accounting for 27.1 percent of online drug operation.
Can the future online pharmacies get a share of the pharmaceutical retail market?Mr Wu said that the outlook for online pharmacies remained unclear because prescription drugs were still unblocked on the Internet.The proportion of drug sales on the Internet is expected to decline further to 24.7 percent in 2017.
Expert: the pharmacy also needs to improve the professional ability
As the reform has entered into the phase of "control cost and efficiency", drug market, before also said goodbye to the barbarian growth, from 2015, pharmaceuticals market growth has been hovering in the single digits, is expected in 2017, China's pharmaceutical market scale will reach 1.5773 trillion yuan, up 5.8% from 2016, the growth continues to fall.
Despite the overall slowdown, retail pharmacies have become a major force in the pharmaceutical industry with a market size of 337.2 billion and high growth.Wu Han points out, want to fully take prescription drugs, retail pharmacies still need to improve professional ability, especially the drug management capabilities, such as drug management and adverse reactions to cope with, in order to improve the service level, meet the demand of public administration.
Scale-up, standardised chains of pharmacy chains will also take the lead.Indeed, as the drug industry has entered a slowdown, retail pharmacies have undergone a "big shuffle".In 2016, the registered amount of drugs for 44.7, 2015 fewer than in 2015, among them, the first decline in the total pharmacy stores, monomer drugstores decreased by 6.9%, at the same time, chain rate is increased by 3.6%, and reached the half, the projected rate of drugstore chain in 2017 will continue to rise.
|
